During the last session, Oruka Therapeutics Inc (NASDAQ:ORKA)’s traded shares were 0.33 million, with the beta value of the company hitting 0.80. At the end of the trading day, the stock’s price was $20.75, reflecting an intraday gain of 1.22% or $0.25. The 52-week high for the ORKA share is $33.00, that puts it down -59.04 from that peak though still a striking 51.47% gain since the share price plummeted to a 52-week low of $10.07. The company’s market capitalization is $726.22M, and the average intraday trading volume over the past 10 days was 0.24 million shares, and the average trade volume was 105.68K shares over the past three months.
Oruka Therapeutics Inc (NASDAQ:ORKA) trade information
Oruka Therapeutics Inc (ORKA) registered a 1.22% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 1.22% in intraday trading to $20.75, hitting a weekly high. The stock’s 5-day price performance is -13.69%, and it has moved by -30.13% in 30 days. Based on these gigs, the overall price performance for the year is 71.93%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The consensus price target of analysts on Wall Street is $40, which implies an increase of 48.12% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $40 and $40 respectively. As a result, ORKA is trading at a discount of -92.77% off the target high and -92.77% off the low.
Oruka Therapeutics Inc (ORKA) estimates and forecasts
Statistics show that Oruka Therapeutics Inc has outperformed its competitors in share price, compared to the industry in which it operates. Oruka Therapeutics Inc (ORKA) shares have gone down -5.16% during the last six months, with a year-to-date growth rate more than the industry average at 30.18% against 16.60.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 48.59%.
ORKA Dividends
Oruka Therapeutics Inc is due to release its next quarterly earnings in December. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Also, the Mutual Funds coming in first place with the largest holdings of Oruka Therapeutics Inc (ORKA) shares are Fidelity Select Portfolios – Health Care and Fidelity Advisor Health Care Fund . Data provided on Sep 30, 2024 indicates that Fidelity Select Portfolios – Health Care owns about 889.35 shares. This amounts to just over 2.54 percent of the company’s overall shares, with a $18.45 million market value. The same data shows that the other fund manager holds slightly less at 561.71, or about 1.60% of the stock, which is worth about $11.66 million.
